Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

Journal of Clinical Investigation

Volumn 116, Issue 7, 2006, Pages 1865-1877

  Fazel, Shafie ^a   Cimini, Massimo ^a   Chen, Liwen ^a   Li, Shuhong ^a   Angoulvant, Denis ^a   Fedak, Paul ^a   Verma, Subodh ^b   Weisel, Richard D ^a   Keating, Armand ^a   Li, Ren Ke ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CYTOKINE; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW RESCUE; CELL MOTILITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HEMATOPOIETIC STEM CELL; MITOGENESIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; UPREGULATION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; CARDIOMYOPATHIES; CYTOKINES; FEMALE; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; RECOMBINANT FUSION PROTEINS; TRANSPLANTATION CHIMERA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33745843261     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27019     Document Type: Article

References (49)

1. Orlic, D., et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98:10344-10349.
2. Orlic, D., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature. 410:701-705.
3. Fazel, S., et al. 2005. Current status of cellular therapy for ischemic heart disease. Ann. Thorac. Surg. 79:S2238-S2247.
4. Balsam, L.B., et al. 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 428:668-673.
5. Murry, C.E., et al. 2004. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 428:664-668.
6. Nygren, J.M., et al. 2004. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494-501.
7. Chabot, B., Stephenson, D.A., Chapman, V.M., Besmer, P., and Bernstein, A. 1988. The protooncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 335:88-89.
8. Beltrami, A.P., et al. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 114:763-776.
9. Kabrun, N., et al. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development. 124:2039-2048.
10. Nishikawa, S.I., Nishikawa, S., Hirashima, M., Matsuyoshi, N., and Kodama, H. 1998. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development. 125:1747-1757.
11. Asahara, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964-967.
12. Rafii, S., and Lyden, D. 2003. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9:702-712.
13. Ikuta, K., and Weissman, I.L. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. U. S. A. 89:1502-1506.
14. Fleming, W.H., Alpern, E.J., Uchida, N., Ikuta, K., and Weissman, I.L. 1993. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 90:3760-3764.
15. Papayannopoulou, T., Priestley, G.V., and Nakamoto, B. 1998. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood. 91:2231-2239.
16. Heissig, B., et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:625-637.
17. Heissig, B., Werb, Z., Rafii, S., and Hattori, K. 2003. Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb. Haemost. 90:570-576.
18. Coussens, L.M., et al. 1999. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13:1382-1397.
19. Starkey, J.R., Crowle, P.K., and Taubenberger, S. 1988. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer. 42:48-52.
20. Okamoto, R., et al. 2005. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood. 105:2757-2763.
21. Nocka, K., et al. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9:1805-1813.
22. Virag, J.I., and Murry, C.E. 2003. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163:2433-2440.
23. Sandhu, R., et al. 2004. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovasc. Res. 64:115-124.
24. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science. 277:48-50.
25. Li, J., et al. 1996. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270:H1803-H1811.
26. Toyofuku, T., et al. 2004. Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol. 6:1204-1211.
27. Wang, B., Golemis, E.A., and Kruh, G.D. 1997. ArgBP2, a multiple Src homology 3 domaincontaining, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. J. Biol. Chem. 272:17542-17550.
28. Irie-Sasaki, J., et al. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature. 409:349-354.
29. Oliveira, D.M., and Goodell, M.A. 2003. Transient RNA interference in hematopoietic progenitors with functional consequences. Genesis. 36:203-208.
30. Jang, Y.Y., Collector, M.I., Baylin, S.B., Diehl, A.M., and Sharkis, S.J. 2004. Hematopoietic stem cells convert into liver cells within days without fusion. Nat. Cell Biol. 6:532-539.
31. McKinney-Freeman, S.L., et al. 2002. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc. Natl. Acad. Sci. U. S. A. 99:1341-1346.
32. Urbich, C., et al. 2005. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39:733-742.
33. Galli, S.J., et al. 1992. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann. N. Y. Acad. Sci. 664:69-88.
34. Urbich, C., and Dimmeler, S. 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95:343-353.
35. Li, T.S., et al. 2003. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am. J. Physiol. Heart Circ. Physiol. 285:H931-H937.
36. Vajkoczy, P., et al. 2003. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J. Exp. Med. 197:1755-1765.
37. Wojakowski, W., et al. 2004. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 110:3213-3220.
38. Kuhlmann, M.T., et al. 2006. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J. Exp. Med. 203:87-97.
39. Asahara, T., et al. 1998. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83:233-240.
40. Hanahan, D., and Folkman, J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353-364.
41. Tait, C.R., and Jones, P.F. 2004. Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204:1-10.
42. Asahara, T., et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221-228.
43. Heissig, B., et al. 2005. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 202:739-750.
44. Ebos, J.M., et al. 2002. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol. Cancer Res. 1:89-95.
45. Spiekermann, K., Faber, F., Voswinckel, R., and Hiddemann, W. 2002. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp. Hematol. 30:767-773.
46. Gailit, J., Marchese, M.J., Kew, R.R., and Gruber, B.L. 2001. The differentiation and function of myofibroblasts is regulated by mast cell mediators. J. Invest. Dermatol. 117:1113-1119.
47. Hara, M., et al. 2002. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195:375-381.
48. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, Y. 1997. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:313-319.
49. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. Reissue edition. National Academy Press. Washington, DC, USA. 140 pp.